243 results on '"Gotto, Geoffrey"'
Search Results
2. Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada
3. Trends and Racial Disparities in the Prevalence of Urinary Incontinence Among Men in the USA, 2001–2020
4. Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces
5. Real-world treatment practices in patients with muscle invasive bladder cancer (MIBC) treated in Alberta, Canada.
6. Practice patterns of high-risk non-muscle invasive bladder cancer (HR-NMIBC) in real-world Canadian practice.
7. PD01-03 THIRD INTERIM ANALYSIS (IA3) OF THE DAROLUTAMIDE OBSERVATIONAL (DAROL) STUDY IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)
8. Addressing controversial areas in the management of advanced prostate cancer in Canada
9. Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
10. An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study
11. Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada
12. Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC)
13. Genetic testing practices among specialist physicians who treat prostate cancer
14. Quality indicators in the management of bladder cancer: A modified Delphi study
15. Nurse-led virtual prostate cancer clinic for survivorship care: Qualitative study of healthcare professional experiences and needs
16. Nurse-led virtual prostate cancer clinic for survivorship care: Qualitative study of patient experiences and needs
17. LBA02-09 EMBARK: A PHASE 3 RANDOMIZED STUDY OF ENZALUTAMIDE OR PLACEBO PLUS LEUPROLIDE ACETATE AND ENZALUTAMIDE MONOTHERAPY IN HIGH-RISK BIOCHEMICALLY RECURRENT PROSTATE CANCER
18. Concordance of “Case Level” Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy
19. Downregulation of BUD31 Promotes Prostate Cancer Cell Proliferation and Migration via Activation of p-AKT and Vimentin In Vitro
20. Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
21. An actionable expert-system algorithm to support nurse-led cancer survivorship care: Algorithm development study (Preprint)
22. The Association between Cyclin Dependent Kinase 2 Associated Protein 1 (CDK2AP1) and Molecular Subtypes of Lethal Prostate Cancer
23. The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder
24. Long term outcome of primary urothelial papilloma: a single institution cohort
25. Extrarenal renal cell carcinoma arising in the kidney proximity but without an identifiable renal primary – an intriguing dilemma: report of three cases and review of the literature
26. Long-term Clinical Outcome of Inverted Urothelial Papilloma Including Cases With Focal Papillary Pattern: Is Continuous Surveillance Necessary?
27. Patterns of care for non‐metastatic castration‐resistant prostate cancer: A population‐based study
28. Outcomes After Resection of Postchemotherapy Residual Neck Mass in Patients With Germ Cell Tumors—An Update
29. Age, Obesity, Medical Comorbidities and Surgical Technique are Predictive of Symptomatic Anastomotic Strictures After Contemporary Radical Prostatectomy
30. Prognostic Impact of Muscular Venous Branch Invasion in Localized Renal Cell Carcinoma Cases
31. Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada
32. Real-world management of metastatic castration-resistant prostate cancer (mCRPC): A national multicenter cohort study.
33. Analysis of the role of PI3K-AKT and DNA damage repair (DDR) genomic biomarkers as predictors of clinical outcomes in nonmetastatic castration-resistant prostate cancer (nmCRPC).
34. Evolving real-world patterns of practice in metastatic castration-sensitive prostate cancer (mCSPC): The genitourinary research consortium (GURC) national multicenter cohort study.
35. Patterns of care for patients with non-metastatic castration-resistant prostate cancer: Population-based study in Ontario, Canada.
36. Real-world treatment patterns, survival outcomes, and health care resource utilization among individuals with nonmuscle-invasive bladder cancer in Canada.
37. Impact of Prior Prostate Radiation on Complications After Radical Prostatectomy
38. Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate Cancer
39. Changes in risk-group stratification of patients undergoing radical prostatectomy at the Southern Alberta Institute of Urology over time
40. Long term outcome of primary urothelial papilloma: a single institution cohort
41. Canadian consensus forum of key controversial areas in the management of advanced prostate cancer
42. Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada
43. Virtual care for prostate cancer survivorship: protocol for an evaluation of a nurse-led algorithm-enhanced virtual clinic implemented at five cancer centres across Canada
44. Temporal Trends in Selecting Patients for Partial Nephrectomy for Small Renal Cell Carcinomas in Alberta, Canada
45. Shock Wave Lithotripsy Correlates With Stone Density on Preoperative Computerized Tomography
46. Geographic variation in systemic therapy in men age 66 years and older with de novo metastatic castration-sensitive prostate cancer: A population-based study in a single payer health-system.
47. Real-world utilization of docetaxel among men with de novo metastatic castration-sensitive prostate cancer: A population-based study in men aged 66 or older.
48. Prognostic association between common laboratory tests and overall survival in men with de novo metastatic castration-sensitive prostate cancer: A population-based study.
49. Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection
50. Social Jetlag and Prostate Cancer Incidence in Alberta’s Tomorrow Project: A Prospective Cohort Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.